These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 22617860

  • 1. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD.
    Arnold VK, Feifel D, Earl CQ, Yang R, Adler LA.
    J Atten Disord; 2014 Feb; 18(2):133-44. PubMed ID: 22617860
    [Abstract] [Full Text] [Related]

  • 2. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.
    Swanson JM, Greenhill LL, Lopez FA, Sedillo A, Earl CQ, Jiang JG, Biederman J.
    J Clin Psychiatry; 2006 Jan; 67(1):137-47. PubMed ID: 16426100
    [Abstract] [Full Text] [Related]

  • 3. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.
    Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA, Modafinil ADHD Study Group.
    J Clin Psychiatry; 2006 May; 67(5):727-35. PubMed ID: 16841622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
    Boellner SW, Earl CQ, Arora S.
    Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M, Ghoreishi A, Rahiminejad F, Mohammadi MR, Kamalipour A, Akhondzadeh S.
    Psychiatry Res; 2009 Aug 15; 168(3):234-7. PubMed ID: 19439364
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder.
    Greenhill LL, Biederman J, Boellner SW, Rugino TA, Sangal RB, Earl CQ, Jiang JG, Swanson JM.
    J Am Acad Child Adolesc Psychiatry; 2006 May 15; 45(5):503-511. PubMed ID: 16601402
    [Abstract] [Full Text] [Related]

  • 9. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.
    Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, Trzepacz PT, Williams DW, Kelsey D.
    J Clin Psychopharmacol; 2009 Feb 15; 29(1):44-50. PubMed ID: 19142107
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
    Weisler RH, Greenbaum M, Arnold V, Yu M, Yan B, Jaffee M, Robertson B.
    CNS Drugs; 2017 Aug 15; 31(8):685-697. PubMed ID: 28712074
    [Abstract] [Full Text] [Related]

  • 11. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J, Pliszka SR.
    J Pediatr; 2008 Mar 15; 152(3):394-9. PubMed ID: 18280848
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults.
    Taylor FB, Russo J.
    J Child Adolesc Psychopharmacol; 2000 Mar 15; 10(4):311-20. PubMed ID: 11191692
    [Abstract] [Full Text] [Related]

  • 13. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.
    Lohr JB, Liu L, Caligiuri MP, Kash TP, May TA, Murphy JD, Ancoli-Israel S.
    Schizophr Res; 2013 Oct 15; 150(1):289-96. PubMed ID: 23938173
    [Abstract] [Full Text] [Related]

  • 14. Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo-Controlled, Randomized Trials.
    Wietecha LA, Clemow DB, Buchanan AS, Young JL, Sarkis EH, Findling RL.
    CNS Neurosci Ther; 2016 Jul 15; 22(7):546-57. PubMed ID: 26922462
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun 15; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 17. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
    Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, Lehert P, Ding CL, Lecomte JM, Schwartz JC, HARMONY I study group.
    Lancet Neurol; 2013 Nov 15; 12(11):1068-75. PubMed ID: 24107292
    [Abstract] [Full Text] [Related]

  • 18. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.
    Spathis A, Fife K, Blackhall F, Dutton S, Bahadori R, Wharton R, O'Brien M, Stone P, Benepal T, Bates N, Wee B.
    J Clin Oncol; 2014 Jun 20; 32(18):1882-8. PubMed ID: 24778393
    [Abstract] [Full Text] [Related]

  • 19. A review of the use of modafinil for attention-deficit hyperactivity disorder.
    Turner D.
    Expert Rev Neurother; 2006 Apr 20; 6(4):455-68. PubMed ID: 16623645
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder.
    Manor I, Ben-Hayun R, Aharon-Peretz J, Salomy D, Weizman A, Daniely Y, Megiddo D, Newcorn JH, Biederman J, Adler LA.
    J Clin Psychiatry; 2012 Dec 20; 73(12):1517-23. PubMed ID: 23290324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.